nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—LIG1—embryo—amyotrophic lateral sclerosis	0.0777	0.142	CbGeAlD
Bleomycin—LIG3—nervous system—amyotrophic lateral sclerosis	0.0403	0.0735	CbGeAlD
Bleomycin—BLMH—medulla oblongata—amyotrophic lateral sclerosis	0.0401	0.0731	CbGeAlD
Bleomycin—LIG3—central nervous system—amyotrophic lateral sclerosis	0.0388	0.0707	CbGeAlD
Bleomycin—LIG3—cerebellum—amyotrophic lateral sclerosis	0.0379	0.0691	CbGeAlD
Bleomycin—LIG1—nervous system—amyotrophic lateral sclerosis	0.0373	0.068	CbGeAlD
Bleomycin—LIG1—central nervous system—amyotrophic lateral sclerosis	0.0359	0.0654	CbGeAlD
Bleomycin—BLMH—spinal cord—amyotrophic lateral sclerosis	0.0357	0.0651	CbGeAlD
Bleomycin—LIG1—cerebellum—amyotrophic lateral sclerosis	0.0351	0.064	CbGeAlD
Bleomycin—LIG3—brain—amyotrophic lateral sclerosis	0.0308	0.0561	CbGeAlD
Bleomycin—BLMH—nervous system—amyotrophic lateral sclerosis	0.0301	0.0549	CbGeAlD
Bleomycin—BLMH—central nervous system—amyotrophic lateral sclerosis	0.029	0.0529	CbGeAlD
Bleomycin—LIG1—brain—amyotrophic lateral sclerosis	0.0285	0.052	CbGeAlD
Bleomycin—BLMH—cerebellum—amyotrophic lateral sclerosis	0.0283	0.0517	CbGeAlD
Bleomycin—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0264	0.068	CcSEcCtD
Bleomycin—BLMH—brain—amyotrophic lateral sclerosis	0.023	0.042	CbGeAlD
Bleomycin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0509	CcSEcCtD
Bleomycin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0405	CcSEcCtD
Bleomycin—Injury—Riluzole—amyotrophic lateral sclerosis	0.0148	0.038	CcSEcCtD
Bleomycin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.014	0.0359	CcSEcCtD
Bleomycin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0287	CcSEcCtD
Bleomycin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0273	CcSEcCtD
Bleomycin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0271	CcSEcCtD
Bleomycin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0265	CcSEcCtD
Bleomycin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0264	CcSEcCtD
Bleomycin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0262	CcSEcCtD
Bleomycin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00998	0.0257	CcSEcCtD
Bleomycin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00944	0.0243	CcSEcCtD
Bleomycin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00939	0.0242	CcSEcCtD
Bleomycin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00935	0.024	CcSEcCtD
Bleomycin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00843	0.0217	CcSEcCtD
Bleomycin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0083	0.0213	CcSEcCtD
Bleomycin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0195	CcSEcCtD
Bleomycin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00756	0.0194	CcSEcCtD
Bleomycin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00738	0.019	CcSEcCtD
Bleomycin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00732	0.0188	CcSEcCtD
Bleomycin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00714	0.0183	CcSEcCtD
Bleomycin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0179	CcSEcCtD
Bleomycin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0179	CcSEcCtD
Bleomycin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0177	CcSEcCtD
Bleomycin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00673	0.0173	CcSEcCtD
Bleomycin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00667	0.0172	CcSEcCtD
Bleomycin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00667	0.0172	CcSEcCtD
Bleomycin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00663	0.017	CcSEcCtD
Bleomycin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00654	0.0168	CcSEcCtD
Bleomycin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00636	0.0164	CcSEcCtD
Bleomycin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00624	0.016	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00608	0.0156	CcSEcCtD
Bleomycin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00599	0.0154	CcSEcCtD
Bleomycin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00595	0.0153	CcSEcCtD
Bleomycin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0058	0.0149	CcSEcCtD
Bleomycin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0147	CcSEcCtD
Bleomycin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0141	CcSEcCtD
Bleomycin—LIG1—HIV Life Cycle—VTA1—amyotrophic lateral sclerosis	0.00533	0.0855	CbGpPWpGaD
Bleomycin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0136	CcSEcCtD
Bleomycin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00528	0.0136	CcSEcCtD
Bleomycin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0126	CcSEcCtD
Bleomycin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00479	0.0123	CcSEcCtD
Bleomycin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00472	0.0121	CcSEcCtD
Bleomycin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0109	CcSEcCtD
Bleomycin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00421	0.0108	CcSEcCtD
Bleomycin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0042	0.0108	CcSEcCtD
Bleomycin—LIG1—HIV Life Cycle—CHMP2B—amyotrophic lateral sclerosis	0.00404	0.0648	CbGpPWpGaD
Bleomycin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00396	0.0102	CcSEcCtD
Bleomycin—LIG1—HIV Infection—VTA1—amyotrophic lateral sclerosis	0.00368	0.0591	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00351	0.0563	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00328	0.0525	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—CHMP2B—amyotrophic lateral sclerosis	0.00279	0.0448	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00267	0.0428	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00213	0.0341	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.00207	0.0332	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00184	0.0294	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00178	0.0286	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00168	0.0269	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.0013	0.0208	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00129	0.0207	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00129	0.0207	CbGpPWpGaD
Bleomycin—BLMH—Immune System—DCTN1—amyotrophic lateral sclerosis	0.00125	0.0201	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.00118	0.0189	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.00116	0.0185	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.00116	0.0185	CbGpPWpGaD
Bleomycin—LIG1—Disease—TPK1—amyotrophic lateral sclerosis	0.00113	0.0181	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.0011	0.0176	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00109	0.0175	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00104	0.0167	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.00101	0.0162	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000983	0.0158	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.00095	0.0152	CbGpPWpGaD
Bleomycin—LIG1—Disease—VTA1—amyotrophic lateral sclerosis	0.000902	0.0145	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000839	0.0135	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000801	0.0129	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ATF1—amyotrophic lateral sclerosis	0.000752	0.0121	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CASP9—amyotrophic lateral sclerosis	0.000716	0.0115	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000709	0.0114	CbGpPWpGaD
Bleomycin—LIG1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000684	0.011	CbGpPWpGaD
Bleomycin—LIG1—Disease—PLB1—amyotrophic lateral sclerosis	0.000619	0.00992	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000613	0.00983	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000588	0.00943	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000576	0.00924	CbGpPWpGaD
Bleomycin—LIG1—Disease—VCP—amyotrophic lateral sclerosis	0.000551	0.00884	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000546	0.00875	CbGpPWpGaD
Bleomycin—BLMH—Immune System—C3—amyotrophic lateral sclerosis	0.000509	0.00816	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000463	0.00742	CbGpPWpGaD
Bleomycin—LIG1—Disease—CST3—amyotrophic lateral sclerosis	0.000396	0.00635	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00035	0.00561	CbGpPWpGaD
Bleomycin—LIG1—Disease—CASP9—amyotrophic lateral sclerosis	0.000288	0.00461	CbGpPWpGaD
Bleomycin—LIG1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000246	0.00395	CbGpPWpGaD
Bleomycin—LIG1—Disease—APOE—amyotrophic lateral sclerosis	0.00019	0.00305	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000151	0.00243	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTGS2—amyotrophic lateral sclerosis	0.000131	0.00209	CbGpPWpGaD
